Q&A with FDA's Alberto Gutierrez
MedSun: Newsletter #58, March 2011

AACC Clinical Laboratory News

Now at the helm of the Food and Drug Administration's (FDA) Office for In Vitro Diagnostics (OIVD) for a year and a half, Alberto Gutierrez, PhD, shared with CLN how FDA is grappling with challenges related to new technologies, shifts in clinical practice, and a move toward greater transparency in the agency’s Center for Devices and Radiological Health, under which OIVD operates.

Additional Information:

AACC Clinical Laboratory News. Q&A with FDA’s Alberto Gutierrez. January 2011.

MedSun Newsletters are available at www.fda.gov/cdrh/medsun